MedTrace Logo

Hepatitis C Diagnosis to Treatment Management

NCT05725109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1063

Last updated 2024-02-16

No results posted yet for this study

Summary

The objective of this study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of hepatitis C treatment. A period of time without alerts will be compared to a period of time with alerts.

Conditions

  • Hepatitis C

Interventions

OTHER

Hepatitis C Treatment Alerts in CHORUS™

Clinical Health Outcomes Reporting \& Utilization Service (CHORUS™) is a web-based healthcare analytics and reporting solution that transforms electronic health record data into meaningful information for healthcare providers. CHORUS™ generates a weekly email report that alerts clinics to patients with certain conditions who have a scheduled appointment in the coming week and may require close attention. CHORUS™ is a service provided to participating clinics and has been used by AIDS Healthcare Foundation for normal healthcare operations for quality improvement and retention in care in recent years. In the after period of this study, the alert will identify patients with active hepatitis C infection.

OTHER

Standard of Care

CHORUS™ is a service provided to participating clinics and has been used by AIDS Healthcare Foundation for normal healthcare operations for quality improvement and retention in care in recent years. NO alerts identifying patients with active hepatitis C infection will be disseminated.

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • AIDS Healthcare Foundation

    collaborator OTHER

  • Epividian

    lead INDUSTRY

Principal Investigators

  • Michael Wohlfeiler, MD · AIDS Healthcare Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-16
Primary Completion
2023-10-17
Completion
2023-10-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05725109 on ClinicalTrials.gov